We observed a decrease in the percentage of CD11b+ LY-6G+ Myeloid-derived suppressor cell (MDSCs), a significant increase in CD11c+ DC and CD3+ T cells, but no significant change in CD11b+ F4/80+ macrophages in the tumor microenvironment of mice treated with WGP compared with CON (Figure 2A). The gene discussed is ITGAX; the disease is neoplasm.